Significance of the D-serine-deaminase and D-serine Metabolism of Staphylococcus Saprophyticus for Virulence
Overview
Authors
Affiliations
Staphylococcus saprophyticus is the only species of Staphylococcus that is typically uropathogenic and possesses a gene coding for a D-serine-deaminase (DsdA). As D-serine is prevalent in urine and toxic or bacteriostatic to many bacteria, it is not surprising that the D-serine-deaminase gene is found in the genome of uropathogens. It has been suggested that D-serine-deaminase or the ability to respond to or to metabolize D-serine is important for virulence. For uropathogenic Escherichia coli (UPEC), a high intracellular D-serine concentration affects expression of virulence factors. S. saprophyticus is able to grow in the presence of high D-serine concentrations; however, its D-serine metabolism has not been described. The activity of the D-serine-deaminase was verified by analyzing the formation of pyruvate from D-serine in different strains with and without D-serine-deaminase. Cocultivation experiments were performed to show that D-serine-deaminase confers a growth advantage to S. saprophyticus in the presence of D-serine. Furthermore, in vivo coinfection experiments showed a disadvantage for the ΔdsdA mutant during urinary tract infection. Expression analysis of known virulence factors by reverse transcription-quantitative PCR (RT-qPCR) showed that the surface-associated lipase Ssp is upregulated in the presence of D-serine. In addition, we show that S. saprophyticus is able to use D-serine as the sole carbon source, but interestingly, D-serine had a negative effect on growth when glucose was also present. Taken together, D-serine metabolism is associated with virulence in S. saprophyticus, as at least one known virulence factor is upregulated in the presence of D-serine and a ΔdsdA mutant was attenuated in virulence murine model of urinary tract infection.
Li X, Pang Y, Jiang L, Liu L, Zhou J, Jin C Nat Commun. 2025; 16(1):607.
PMID: 39799152 PMC: 11724981. DOI: 10.1038/s41467-025-55982-z.
Connolly J, Turner N, Serrano E, Rimbi P, Browning D, OBoyle N Proc Natl Acad Sci U S A. 2022; 119(45):e2210299119.
PMID: 36322762 PMC: 9659370. DOI: 10.1073/pnas.2210299119.
Brauer A, Learman B, Taddei S, Deka N, Hunt B, Armbruster C Mol Microbiol. 2022; 118(3):125-144.
PMID: 35970717 PMC: 9486832. DOI: 10.1111/mmi.14968.
From Clinical and Environmental Origins Have Distinct Biofilm Composition.
Lawal O, Barata M, Fraqueza M, Worning P, Bartels M, Goncalves L Front Microbiol. 2021; 12:663768.
PMID: 34163443 PMC: 8216562. DOI: 10.3389/fmicb.2021.663768.
Zhu X, Arfaoui A, Sayari M, Adam L, Daayf F Pathogens. 2021; 10(5).
PMID: 33922492 PMC: 8146963. DOI: 10.3390/pathogens10050510.